Company ProfilePremium

Lam Soon (Hong Kong) Limited

Company Profile Analysis

Ticker: 0411.HK南順

ESOMAR 23 Corporate BadgeISO Certifications Badge
Lam Soon (Hong Kong) Limited - Company showcase

Year Founded & Workforce

1961

1,480 Employees

Lam Soon (Hong Kong) Limited logo

Lam Soon (Hong Kong) Limited Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Lam Soon (Hong Kong) Limited Overview

Lam Soon (Hong Kong) is a Hong Kong-domiciled, Hong Leong Group-controlled manufacturer of branded staple foods and household cleaning products. Most of its sales and production are in Mainland China, while Hong Kong and Macau provide the brand heritage. The Food segment (about 81% of FY2026 revenue) combines premium bakery flour (Golden Statue, American Roses, Royal Sakura, Double Peach), specialty fats for food manufacturers, and consumer edible oils led by Knife, the Hong Kong peanut-oil leader. The Home Care segment (about 19%) is anchored by AXE, Hong Kong's leading dishwashing brand, and is growing in southern China. The company is mature and modestly profitable, with a net margin of 5.8% in FY2026. It has a fortress balance sheet: HK$2.06 billion in cash, no bank debt, and net cash equal to about 77% of market value. It pays dividends that yield roughly 4–5%. The investment case rests on cash returns, a deep valuation discount and possible take-private optionality, rather than on growth.


Company's own description (paraphrased from FY2026 results, note 3)

The Group reports two segments. Food covers the manufacture and distribution of a wide range of food products, including flour, edible oils and specialty fats. Home Care covers the manufacture and distribution of household and institutional cleaning products. All revenue is recognized at a point in time from the sale of goods. There is no service, subscription or licensing revenue (FY2026 results, note 4).

Third-party profiles based on company disclosures give more detail. Food serves both the catering industry and consumers. Home Care products include liquid dishwashing detergent, laundry powder, liquid laundry detergent, fabric softener, floor cleaner and industrial marble cleanser (Morningstar company profile).

Business model and revenue model

Revenue mix: 100% product sales (FY2026: HK$5,063 million, all "sales of goods"). There is no licensing, royalty or recurring service income.

Value chain position: Lam Soon is a midstream processor and brand owner. It buys agricultural commodities (wheat, including directly sourced imported wheat; peanuts; palm and other vegetable oils) and petrochemical inputs (surfactants, plastic packaging resin). It mills, refines, blends and formulates these into branded and customer-specific finished goods, then sells through retail, e-commerce, distributors and key accounts. It does not own upstream farmland or downstream retail.

Economic engine: Gross margins of about 17–23% (FY2022–FY2026) depend on the spread between commodity costs and selling prices. In flour, the company earns a premium through Japanese-style and specialty bakery formulations and technical service. In oil and home care, brand equity drives the premium. Profit is highly sensitive to wheat, oilseed and petroleum-linked input prices. This was shown in FY2023, when wheat costs linked to the Ukraine war cut net profit by 67%, and again in FY2026, when Middle East-driven surfactant and packaging inflation cut Home Care operating profit by 30%.

Tax feature: Flour milling in Mainland China counts as primary processing of agricultural products and is exempt from PRC corporate income tax. Other Mainland subsidiaries pay 25% (FY2026 results, note 6). This structurally supports Food segment after-tax returns.

Customer types and end-markets

Customer typeSegmentExamples / channel (per FY2026 commentary)
Industrial bakeries, food manufacturers, larger key accounts, new-retail platformsFood (Flour, Specialty Fats)Customer-specific formulations, technical support and co-development; growth is moving from traditional bakery channels to large key accounts and new retail
Traditional bakeries and cateringFoodCoverage being optimized; supported by industry events such as the Golden Statue Cup bread competition
Retail consumers (supermarkets, e-commerce, O2O)Food (Edible Oil), Home CareKnife oils in Hong Kong and Mainland China; AXE in Hong Kong; e-commerce growing
Institutional cleaning customersHome CareHotels, central kitchens, restaurant chains and food plants; historic Procleanic line (FY2009 results describe institutional products for food plants, hotels, central kitchens and fast-food chains)

Geography: Mainland China contributed 86.2% of FY2026 revenue (HK$4,367 million) and Hong Kong and Macau 13.8% (HK$696 million) (FY2026 results, note 3(c)).

Independent characterization

Lam Soon is effectively a Mainland China B2B flour and specialty-fats business with a smaller branded consumer business attached. In Hong Kong it has iconic brands (Knife, AXE) whose market leadership is out of proportion to their revenue weight. The Food segment produces about 83% of segment operating profit. Within Food, the commentary suggests flour and specialty fats are the more resilient profit pool, while edible oil faces stiff price competition. Home Care is the growth engine by revenue (+10% in FY2026) but is the more volatile profit pool. The balance sheet is over-capitalized: cash is about 50% of total assets, which depresses ROE to about 9% despite segment returns that are healthy on invested operating capital.

Strategy

Stated strategy themes (paraphrased from the FY2026 results outlook and review)

  1. Sharper prioritization: put resources into fewer, higher-impact opportunities across products, customers and channels.

  2. Innovation and customer solutions: strengthen R&D, technical service and co-development, especially integrated flour-plus-specialty-fats solutions for key accounts.

  3. Recurring cost competitiveness: make structural savings routine through direct wheat sourcing, wheat-mix and formulation optimization, and process and logistics improvements.

  4. Simplification and productivity: simplify structures and processes and raise organizational productivity. FY2026 head-office costs fell 25%.

  5. Selective investment under clear hurdles: invest in people, R&D, digitalization, automation and manufacturing capability, subject to strategic and financial hurdles.

  6. Brand value over price: in edible oil, compete on quality, health and differentiated benefits rather than price; in Home Care, use differentiated products, channel-specific offerings and disciplined promotion.

The FY2025 themes (FY2025 results, Stock News summary) were selective price adjustments to defend volume and share, flexible procurement, opex discipline, and investment in talent, digital and R&D infrastructure and new product development. The H1 FY2026 themes (interim results) were disciplined margin and cost control, channel management, and selective investment in product development and digital initiatives.

Initiatives in the last 24 months

InitiativeTimingDetailSource
Conghua Home Care plantAnnounced (date not confirmed); in constructionRMB337 million new plant expected in FY2026/27; capacity, automation, integrated R&D and manufacturingTipRanks; FY2026 results
Shanghai R&D hubLaunched Q2 2026Fundamental ingredient research, formulation control, supplier and institution collaboration, portfolio expansion beyond dishwashingFY2026 results
Qingzhou flour line upgradeCommissioned in FY2026Local premium Japanese-style flour (Royal Sakura, Golden Statue) for North ChinaFY2026 results
Jintan specialty fats upgradesFY2026Broader product capabilityFY2026 results
Direct imported-wheat sourcingFY2026Structural procurement savings and supply resilienceFY2026 results
Knife health range (Hong Kong)FY2026Zero-trans-fat peanut oil and non-GMO canola; Carlos Chan campaignFY2026 results
Knife × General Administration of Sport of China Training BureauFY2026Strategic collaboration on quality and health positioningFY2026 results
Academic and industry collaborations (edible oil)FY2026Aroma enhancement, nutrition, product stability, edible-oil standardsFY2026 results
Golden Statue Cup, HK and Macau regional selectionFY2026Pathway for HK and Macau bakers into the iba UIBC 2027 World Championship of Bread China SelectionFY2026 results
Home Care cost responseFY2026Pricing actions, alternative sourcing, reformulation, promotional disciplineFY2026 results
Sustainability commitmentsOngoingESG reports published in Annual Reports (for example, the Annual Report 2023 ESG section)Annual Report 2023

Medium-term targets and guidance

Management does not publish quantified medium-term financial targets, revenue or margin guidance. Not publicly disclosed. The FY2026 outlook is qualitative: conditions are expected to stay demanding, with continued price competition, channel shifts, geopolitical uncertainty and commodity volatility.

Products & Services

The company does not publish SKU-level specifications or prices. The catalog below combines disclosed brands (company descriptions syndicated by Simply Wall St, Yahoo Finance and Morningstar) with product facts from the results announcements. Pricing models are not publicly disclosed for any product beyond the fact that all revenue comes from goods sold at a point in time.

Food segment — Flour

Brand / lineDescriptionTarget customerNotes / latest development
Golden Statue (金像牌)Flagship premium bread flour; long-standing core brand in Hong Kong and southern ChinaBakeries, industrial bakers, key accountsFY2026: produced locally in North China after the Qingzhou line upgrade. Lends its name to the "Golden Statue Cup," the China Selection for the iba UIBC 2027 World Championship of Bread; FY2026 added an inaugural Hong Kong and Macau regional selection.
American Roses (美玫牌)Core flour brand for cakes, pastries and general bakeryBakeries, food serviceNamed as a core brand in Annual Reports 2007 and 2020
Royal SakuraPremium Japanese-style flourPremium bakeries, key accountsFY2026: Qingzhou upgrade adds premium Japanese-style flour capacity in North China alongside existing East China capacity
Double PeachFlour brand in the portfolio—Disclosed brand; positioning not publicly disclosed
Customer-specific floursCustomized formulations co-developed with technical service and R&DLarge key accounts and new-retail platformsFY2026: strong sales and gross-profit growth in customer-specific products, with integrated flour-plus-fats solutions

Food segment — Specialty Fats

LineDescriptionTarget customerNotes
Specialty and vegetable fatsBakery and food-manufacturing fats sold alongside flour as integrated solutionsCatering industry, food manufacturers, bakeriesStill a small base. FY2026: selected upgrades at the Jintan plant widened product capability; priorities are customer base, mix and plant utilization. Brand names not publicly disclosed.

Food segment — Edible Oil

Brand / lineDescriptionTarget customerNotes / latest development
Knife (刀嘜)Flagship consumer edible-oil brand, launched in 1948; leader in Hong Kong retail peanut oil (FY2022 results)Households in Hong Kong and GuangdongFY2026 Hong Kong launch of a health range: zero-trans-fat peanut oil and zero-trans-fat non-GMO canola oil, backed by a brand campaign with Carlos Chan. In Mainland China, a strategic collaboration with the Training Bureau of the General Administration of Sport of China supports the brand's quality and health positioning.
Red Lantern (紅燈)Edible oil brand; repositioned around a health-food image (FY2010 results)ConsumersCore brand historically (Annual Report 2007); current scale not disclosed
SoonDisclosed brand in the oil and food portfolio——

Home Care segment

Brand / lineDescriptionTarget customerNotes / latest development
AXE (斧頭牌)Flagship dishwashing liquid, introduced in 1969; Hong Kong market leader in dishwashing; also sold in adjacent categoriesHouseholds in Hong Kong and southern ChinaNamed a Hong Kong Top Ten Brand (2000). FY2023: AXE Supra launched in the super-concentrated dishwashing segment. FY2026: leadership held despite heavy promotional competition; selective expansion into adjacent categories.
LabourDetergent brandValue-conscious householdsCore brand historically (Annual Report 2007)
ProcleanicInstitutional and professional cleaning rangeFood plants, hotels, central kitchens, restaurant and fast-food chainsInstitutional products described in FY2009 results; current scale not disclosed
Product typesLiquid dishwashing detergent, laundry powder, liquid laundry detergent, fabric softener, floor cleaner, industrial marble cleanserHouseholds and institutionsMorningstar company profile
PipelinePortfolio expansion beyond dishwashing, supported by the Shanghai R&D hub (Q2 2026) and the Conghua plant (under construction)—FY2026 results

Discontinued lines

LineStatusSource
Manuka honey distribution (China)Ended 30 June 2022 when the agency agreement expired; described as very small with minimal profit impactFY2022 results
Frozen food division (Lam Soon Food Industries era)Historical; not part of current reportingAnnual Report 2000
Telecom and internet diversification (1990s)Exited after the Hong Leong takeoverBamboo Works

Financial Narrative

Income statement headline

Sources: final results announcements FY2022, FY2023 and FY2026; Annual Report 2024 five-year summary; FY2025 results (Stock News, 16 Sep 2025). FY2024 gross profit is derived from the disclosed 10% growth in FY2025 gross profit to HK$1,119 million. Diluted EPS equals basic EPS because there were no dilutive instruments (FY2026 note 8).

Revenue CAGR: FY2022–FY2026 −4.6% p.a.; FY2021–FY2026 −2.5% p.a. (FY2021 revenue HK$5,761 million). Both derived.

Longer earnings and dividend context: notes and sources

Sources: Annual Report 2023 five-year summary (FY2019–FY2023); Annual Report 2024; FY2025 and FY2026 results.

Detailed P&L

Historical pre-tax profit: FY2019 HK$398 million; FY2020 HK$400 million; FY2021 HK$421 million; FY2022 HK$285 million; FY2023 HK$90 million (Annual Report 2023).

Commentary. Earnings have followed commodity cycles more than demand cycles. FY2022 revenue peaked at HK$6.1 billion because commodity pass-through inflated prices, but gross margin fell to 18.7% as costs outran pricing. FY2023 was the trough: wheat costs tied to the Ukraine war, weaker volumes and a weaker RMB cut revenue 16% and net profit 67% to HK$85 million (profit warning 31 Jul 2023). The recovery in FY2024–FY2025 came from margin rather than volume. Revenue kept declining, but cheaper wheat and oil, flexible procurement and opex control lifted gross margin to 23.2% and net profit to HK$303 million in FY2025, up 51% (FY2025 results). FY2026 marks an inflection to top-line growth (+5% reported, +2% constant currency). However, S&D spending rose 7%, other income fell (lower FX gains and no dividend income) and Home Care inputs inflated, so operating profit fell 3%. Lower head-office costs (HK$49.6 million versus HK$65.8 million) partly offset these pressures.

Balance sheet

Source: FY2026 results, consolidated statement of financial position. Total assets derived as non-current plus current assets.

Sources: interim and final results announcements (FY2021: interim FY2022; FY2022: interim FY2023; FY2023: interim FY2024). Total equity was HK$2,477 million at June 2020 and HK$2,881 million at June 2021 (FY2021 results). Cash at 31 December 2023 was HK$1,544 million.

Cash composition (30 Jun 2026): about 40% HKD, 36% RMB, 24% USD. Undrawn bank facilities: HK$400 million (FY2025: HK$589 million). Equity-to-debt ratio: 100:0 (FY2026 results).

Cash flow

Operating cash flow and free cash flow: not disclosed in the preliminary announcement; the full cash flow statement will be in the Annual Report 2026. FY2026 dividends paid comprise the FY2025 final (HK$77.4 million) plus the FY2026 interim (HK$35.2 million). FY2025 dividends paid comprise the FY2024 final (HK$63.4 million at HK$0.27) plus the FY2025 interim (HK$35.2 million). There was no company buyback in FY2026; the only share purchases were 229,000 shares bought by the share-scheme trustee for about HK$2.56 million.

Implied cash generation. Cash rose HK$143 million in FY2026 after HK$129 million of capex, HK$113 million of dividends and HK$3 million of trust share purchases. This implies operating cash flow of roughly HK$390 million before FX translation effects on cash, which cannot be isolated from the announcement. It is consistent with EBITDA of about HK$420 million and a modest working-capital build: receivables rose HK$123 million, mostly "other receivables, deposits and prepayments," which may include Conghua construction deposits.

Ratios (derived from FY2026 results unless stated)

ROIC is defined as profit from operations minus interest income, taxed at the effective rate, divided by equity plus lease liabilities minus cash. Interest coverage is not meaningful because the only finance cost is lease interest. The inventory-day improvement from 81 to 70 days is a notable FY2026 working-capital gain.

Trend commentary. Profitability is constrained by over-capitalization rather than weak operations. Excluding cash, the business earned about 18–21% post-tax on invested capital in FY2025–FY2026, an attractive return for a commodity processor. Cash yields about 2.4% (HK$48 million of interest on about HK$2 billion), and holding it pulls group ROE down to about 9%. Liquidity is extremely strong (current ratio about 4.7x), and gearing is nil.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Revenue by Segment

SegmentFY2021FY2022FY2023FY2025FY2026

Food revenue (HKD Mn)

4,9575,2844,3263,9474,089

Home Care revenue (HKD Mn)

805823793883974

Group revenue (HKD Mn)

5,7616,1075,1194,8295,063

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Results by Segment and Segment Margins & Growth (%)

MetricFY2025FY2026

Food profit from operations (HKD Mn)

293.1298.8

Home Care profit from operations (HKD Mn)

87.561.3

Total segment profit (HKD Mn)

380.6360.0

Food operating margin (%)

7.47.3

Home Care operating margin (%)

9.96.3

Food share of revenue (%)

81.780.8

Home Care share of revenue (%)

18.319.2

Food share of segment profit (%)

77.083.0

Results by Segment and Segment Margins & Growth (%) (FY2021–FY2026)

MetricFY2021FY2022FY2023FY2025FY2026

Home Care profit from operations (HKD Mn)

8655738861

Home Care operating margin (%)

10.76.79.29.96.3

Segment Margins & Growth (%)

MetricFY2022FY2023FY2026

Food revenue growth (%)

7-184

Home Care revenue growth (%)

2-410

Home Care operating profit growth (%)

-3633-30

Revenue by Segment (Half-Yearly)

MetricH1 FY2025H2 FY2025H1 FY2026H2 FY2026

Group revenue (HKD Mn)

2,6812,1482,6702,393

Food revenue (HKD Mn)

2,2081,7392,1701,919

Home Care revenue (HKD Mn)

468415495479

Food operating profit (HKD Mn)

19598184115

Home Care operating profit (HKD Mn)

55334021

Profit for the period (HKD Mn)

188115176117

Segment Assets & Liabilities

MetricFY2025FY2026

Food segment assets (HKD Mn)

2,2162,270

Home Care segment assets (HKD Mn)

330398

Food segment liabilities (HKD Mn)

484519

Home Care segment liabilities (HKD Mn)

153197

Income Statement and Per-Share Data

MetricFY2022FY2023FY2024FY2025FY2026

Revenue (HKD Mn)

6,1075,1194,8384,8295,063

Gross profit (HKD Mn; FY2024 derived)

1,1438761,0171,1191,160

Profit for the year (HKD Mn)

25785201303293

Basic EPS (HKD)

1.090.360.851.291.25

Diluted EPS (HKD)

1.090.360.851.291.25

Dividend per share (HKD)

0.480.300.400.480.50

Gross margin (%)

18.717.121.023.222.9

Net margin (%)

4.21.74.26.35.8

Revenue growth (%)

6.0-16.2-5.5-0.24.8

Income Statement and Per-Share Data (FY2019–FY2026)

MetricFY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026

Revenue (HKD Mn)

5,3165,1195,7616,1075,1194,8384,8295,063

Profit for the year (HKD Mn)

34031735825785201303293

Dividend per share (HKD)

0.440.450.480.480.300.400.480.50

Income Statement

Line itemFY2025FY2026

Revenue (HKD Mn)

4,829.25,063.1

Cost of sales (HKD Mn)

3,710.73,903.3

Gross profit (HKD Mn)

1,118.51,159.8

Other income (HKD Mn)

70.254.9

Selling and distribution expenses (HKD Mn)

601.6643.8

Administrative expenses (HKD Mn)

225.7222.0

Profit from operations (HKD Mn)

361.5348.9

Finance costs, leases only (HKD Mn)

0.40.6

Profit before taxation (HKD Mn)

361.1348.2

Taxation (HKD Mn)

58.154.9

Profit for the year (HKD Mn)

303.0293.4

Depreciation and amortisation (HKD Mn)

73.272.8

EBITDA = operating profit + D&A (HKD Mn)

434.7421.7

Interest income (HKD Mn)

48.748.4

EBITDA excluding interest income (HKD Mn)

386.0373.3

Staff costs (HKD Mn)

486.2501.6

Margin Analysis (%)

RatioFY2025FY2026

Gross margin (%)

23.222.9

Operating margin (%)

7.56.9

EBITDA margin (%)

9.08.3

Pre-tax margin (%)

7.56.9

Net margin (%)

6.35.8

S&D expenses / revenue (%)

12.512.7

Admin expenses / revenue (%)

4.74.4

Effective tax rate (%)

16.115.8

Balance Sheet

MetricFY2025FY2026

Total assets (HKD Mn)

3,8064,147

Cash and deposits (HKD Mn)

1,9162,059

Bank borrowings, short-term (HKD Mn)

00

Bank borrowings, long-term (HKD Mn)

00

Lease liabilities, total (HKD Mn)

12.317.3

Net cash, after leases (HKD Mn)

1,9032,041

Total equity (HKD Mn)

3,1403,416

Intangible assets and goodwill (HKD Mn)

9.912.2

Property, plant and equipment incl. leasehold land (HKD Mn)

705.8802.1

Inventories (HKD Mn)

745.1725.3

Trade and other receivables (HKD Mn)

381.4504.3

Trade and other payables (HKD Mn)

595.9640.3

Net current assets (HKD Mn)

2,3952,581

Operating working capital, ex-cash (HKD Mn; derived)

480523

Key Financials

MetricFY2021FY2022FY2023FY2025FY2026

Cash balance at 30 June (HKD Mn)

1,4851,5411,4571,9162,059

Cash Flow

MetricFY2025FY2026

Capital expenditure (HKD Mn)

59129

Dividends paid in the year (HKD Mn; derived from note 7)

98.6112.6

Share purchases by Executive Share Scheme trust (HKD Mn)

02.6

Increase in cash balance (HKD Mn)

0143

Returns & Leverage Ratios (%) and Financial Ratios (x)

RatioFY2025FY2026

ROE, average equity (%)

9.68.9

ROA, average or year-end assets (%)

8.07.4

ROIC, ex-cash, post-tax (%)

21.218.4

Current ratio (x)

4.704.65

Debt to equity, bank debt (%)

00

Net debt / EBITDA (x; net cash shown as negative)

-4.4-4.8

Interest coverage, operating profit / lease interest (x)

853555

Asset turnover (x)

1.271.27

Inventory days (company-reported)

8170

Receivable days (company-reported)

2423

Payable days (derived, trade payables / COGS)

3033

Cash conversion cycle (days; derived)

7560

Revenue by Region and Revenue by Region (%)

RegionFY2025FY2026

Chinese Mainland revenue (HKD Mn)

4,1304,367

Hong Kong and Macau revenue (HKD Mn)

699696

Total revenue (HKD Mn)

4,8295,063

Chinese Mainland share (%)

85.586.2

Hong Kong and Macau share (%)

14.513.8

Chinese Mainland growth (%)

05.7

Hong Kong and Macau growth (%)

0-0.4

Valuation Snapshot

MetricValueSource

Recent price

About HK$11.00 (mid-Sep 2026, after results); HK$11.30 (30 Jun 2026)

Bamboo Works; Google Finance

52-week range (as of 30 Jun 2026)

HK$9.90 – HK$13.00

Google Finance

10-year price performance

About HK$8.50 to about HK$11 (+about 30%); total return about +80% including HK$4.28 of cumulative dividends

Bamboo Works, Sep 2026

Beta

0.31

Snowball Analytics

Average daily volume

About 2,769 shares

TipRanks

Analyst coverage

0 analysts

Simply Wall St

Valuation Multiples

MultipleLam SoonPeer reference

P/E (trailing)

8.8x (HK$11.00 / EPS HK$1.25); Bamboo Works cites about 9x

Arowana about 47x

P/B

About 0.78x on issued shares (BVPS about HK$14.04) or about 0.76x on outstanding shares; Bamboo Works cites 0.85x (the difference reflects share-count and price basis)

Arowana 1.56x

EV/EBITDA

About 1.5x (EV about HK$636 million = HK$2,677 million market cap − HK$2,041 million net cash; EBITDA HK$421.7 million)

—

EV/Sales

About 0.13x

—

Dividend yield

About 4.5% (HK$0.50 / HK$11.00)

—

Per-Share Data and Returns & Leverage Ratios (%)

MetricFY2020FY2021FY2022FY2023FY2024FY2025FY2026

Interim DPS (HKD)

0.140.150.150.100.130.150.15

Final DPS (HKD)

0.310.330.330.200.270.330.35

Total DPS (HKD)

0.450.480.480.300.400.480.50

Basic EPS (HKD)

1.341.511.090.360.851.291.25

Payout ratio (%)

34324483473740

Analyst Conclusions

Management guidance

The company gives qualitative guidance only. It expects operating conditions to stay demanding, with price competition, channel shifts, geopolitical uncertainty and commodity volatility. Its response will be sharper prioritization, innovation and customer solutions, recurring cost competitiveness, simplification, and selective investment under explicit hurdles (FY2026 results). No consensus estimates exist because there is no analyst coverage.

Bull case

  1. Valuation and cash backing: at about HK$11, net cash covers about 77% of market value, and the operating business trades at about 1.5x EBITDA while earning about 18% post-tax ROIC.

  2. Home Care margin rebound and Conghua: Home Care revenue grew 10% in FY2026 while margin fell to 6.3% only because of input costs. A reversion toward the FY2025 margin of 9.9% on HK$974 million of revenue would add about HK$35 million of operating profit, before Conghua efficiencies.

  3. Privatization optionality: Hong Leong owns about 60%, the free float is about 27% and the stock trades below book. Three Hong Kong edible-oil peers were taken private between 2020 and 2022, so a premium offer is plausible but unconfirmed.

Bear case

  1. Structural revenue erosion: revenue fell from HK$6.1 billion (FY2022) to HK$5.1 billion (FY2026), a CAGR of −4.6%, and constant-currency growth in FY2026 was only 2%.

  2. Commodity and geopolitical exposure: profits swing sharply with input costs, from HK$257 million to HK$85 million to HK$303 million between FY2022 and FY2025. FY2026 showed Middle East shocks can cut Home Care profit by 30% within a year.

  3. Value trap dynamics: with no catalyst, minimal liquidity, frequent CEO turnover and cash earning only about 2.4%, the discount can persist indefinitely, and a take-private could be priced opportunistically.

Catalysts and monitorables (next 12 months)

ItemTiming
Annual Report 2026 (cash flow statement, compensation, ESG data)About Oct 2026
AGM vote; FY2026 final dividend HK$0.3511 Nov 2026; payment 3 Dec 2026
H1 FY2027 interim results: Home Care margin trajectory, Mainland demandAbout late Feb 2027
Conghua plant commissioning (target FY2026/27)During FY2027
Petroleum-linked input prices (surfactants, PE/PP resin); wheat and palm-oil pricesContinuous
RMB/HKD exchange rate (translation effect on 86% of revenue)Continuous
Any capital-return change (special dividend, buyback) or controlling-shareholder actionEvent-driven
CEO Lim's first full-year execution record and management bench stabilityFY2027

Analyst verdict

Lam Soon (Hong Kong) is a well-run but structurally ex-growth staples processor. It is cheap because the market ignores it, not because it is impaired. The operating business is sound. Food holds a resilient 7% operating margin backed by a premium flour franchise, technical-service relationships and a PRC tax exemption. Home Care is gaining share and scale in southern China, even though petroleum-linked inputs halved its second-half profitability in FY2026. Working capital is tightening, capex is being put into productivity (Qingzhou, Jintan, Conghua), and the company has turned back to revenue growth for the first time since FY2022.

The flaw is capital structure and governance rather than operations. Over HK$2 billion of cash earns about 2% and dilutes ROE to under 9%. Free float is thin, institutional ownership is negligible, and three CEOs in about 13 months points to an unresolved leadership model, now settled for the time being on an insider. Dividends are reliable and rising (HK$0.50 in FY2026, a 40% payout, about 4.5% yield), but they absorb only a small share of excess capital.

At about 8.8x earnings, about 0.8x book and about 1.5x EV/EBITDA, investors are paid well to wait for the risk/reward to work. The downside is cushioned by net cash of roughly HK$8.70 per share on the outstanding share count, and upside can come from three directions: normalization of Home Care margins, a higher payout or special distribution, or a take-private by Hong Leong. The last is unconfirmed, but the setup is consistent with the sector's privatization wave.

The key risk is not insolvency but stagnation: years of flat earnings and a persistent discount if commodity shocks keep recurring. For income-oriented, patient, liquidity-tolerant investors, the analyst view is that Lam Soon offers asymmetric value. It is not suited to growth or liquidity-sensitive mandates.


Principal sources: Lam Soon (HK) Final Results Announcements for FY2021, FY2022, FY2023 and FY2026 (HKEX: 23 Aug 2021, 24 Aug 2022, 1 Sep 2023, 7 Sep 2026); Interim Results announcements (Feb 2021, Feb 2022, Feb 2023, 20 Feb 2024); Annual Reports 2000, 2007, 2010, 2020, 2023 and 2024; HKEX announcements of 10 Nov 2022, 31 Jul 2023, 2 Feb 2024, 23 Feb 2024, 17 Apr 2024, 24 May 2024 and 15 Apr 2025; HKEX Disclosure of Interests filings (2003–2006); Lam Soon Food Industries Annual Report 2001; Bamboo Works (15 Sep 2026); FilingReader (7 Sep 2026); Stock News / Tiger Brokers bulletins (16 Sep 2025, 12 Nov 2025, 25 Feb 2026); Simply Wall St; Morningstar; Google Finance; TipRanks; Snowball Analytics; Industrial History of Hong Kong.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameRoleTenure / appointmentBackground (as disclosed)

KWEK Leng Hai

Chairman (non-executive)

Director since at least 2000; Chairman by 2016

Qualified Chartered Accountant (Annual Report 2000). Holds 2,300,000 shares (about 0.95%).

LIM Shueh Hann

Executive Director and CEO

Since 1 May 2025; joined the company in 2014

Previously General Manager of the Home Care Division, with e-commerce and corporate development experience at the company. Earlier a Senior Analyst in Morgan Stanley's Asia Pacific Financial Institutions Group (Hong Kong), working on US and HK equity capital markets deals. Holds 258,000 shares. Age not disclosed in sources reviewed. (HKEX, 15 Apr 2025)

Christian K. NOTHHAFT

Non-Executive Director

Since 18 Apr 2024

Executive Director and CEO of Guoco Group Limited (HKEX-listed). INED of DFI Retail Group. Former CEO of Watsons Personal Care Stores China and MD of Watsons Wine and Fortress Hong Kong. (HKEX, 17 Apr 2024)

WHANG Yixiang Remus

Non-Executive Director

Since 12 Nov 2025

Represents the Whang family line (the Whang family holds about 11.3%). Appears to be the appointee described as ED and Group CEO of MC Packaging Pte Ltd, formerly at Evercore and in Guoco Group business development overseeing FMCG assets, with a Wharton BSc in Economics. This mapping is inferred from a summarized bulletin and should be verified against the HKEX announcement of 12 Nov 2025.

HO Yuk Wai, Joan

Independent NED

On board since at least Feb 2021

Not detailed in sources reviewed

CHEUNG Man Ying (Ms.)

Independent NED

Since 12 Nov 2025

Likely the appointee described as a Fellow, council member (since 2021) and vice president (since 2024) of the Hong Kong Chartered Governance Institute (inferred mapping)

CHAU Siu Lun

Independent NED

Since 12 Nov 2025

Likely the appointee described as a solicitor qualified in Hong Kong and England and Wales, partner at Haiwen & Partners, and formerly a partner at Herbert Smith Freehills (2006–2022) and head of its Beijing office (2011–2022) (inferred mapping)

Board & Management Changes

DateChangeContext

23 Feb 2024 (effective 18 Apr 2024)

Wong Cho Fai retires as Group MD/CEO

Board said there was no disagreement and began a search

17 Apr 2024 (effective 18 Apr 2024 and 15 May 2024)

Nothhaft appointed NED; NED Chew Seong Aun retires

Strengthens the Guoco/Hong Leong link on the board

24 May 2024 (effective 3 Jun 2024)

James Chiu Chao Hsiang appointed CEO and ED

External hire with nutritional and healthcare products experience

15 Apr 2025 (effective 1 May 2025)

Chiu resigns to pursue other endeavors; Lim Shueh Hann appointed CEO and ED

Internal successor after an 11-month external tenure, meaning three CEOs in about 13 months

Aug 2025

Company secretary changes from Cheng Man Ying to Stella Lo

Approved by written resolution (CG deviation)

12 Nov 2025

Whang Sun Tze (NED) retires on age; Lester Huang (INED for 11+ years) does not seek re-election; Whang Yixiang Remus (NED) and two INEDs appointed

Generational and independence refresh

Major Shareholders

HolderShares% of issued (243.35M)Source

Hong Leong Company (Malaysia) Berhad, via GuoLine International Ltd

146,789,65960.3

Simply Wall St (S&P Capital IQ), Nov 2025

Dr. Whang Sun Tze and related parties (Whang & Company, SGR Investment, Raven Investment)

27,523,74311.3

Simply Wall St; Bamboo Works cites 11.28%

Kwek Leng Hai

2,300,0000.95

Simply Wall St

Dimensional Fund Advisors LP

337,3100.14

Simply Wall St

Lim Shueh Hann

258,0000.11

HKEX, 15 Apr 2025

Lester Garson Huang

150,0000.06

Simply Wall St (pre-departure)

SGR Investment Company Limited

18,4570.01

Simply Wall St

Competitive Landscape

Competitors by Segment

SegmentCompetitorTypeRelative positioning

Edible oil (China)

Yihai Kerry Arawana (300999.SZ; Wilmar subsidiary; Arawana/Golden Dragon Fish)

Listed giant

China's largest packaged edible-oil player; scale leader far above Lam Soon

Edible oil (China)

COFCO (Fortune brand; former listed arm China Agri-Industries privatized 2020)

State-owned

National scale, upstream integration

Edible oil (China)

Luhua Group (peanut oil)

Private

Peanut-oil specialist and direct rival to Knife in the premium peanut segment

Edible oil (China)

Changshouhua Food (corn oil; privatized 2020)

Private (formerly listed)

Corn-oil specialist

Edible oil (Hong Kong)

Hop Hing Group (Lion & Globe; privatized 2022)

Private (formerly listed)

Lam Soon's main Hong Kong edible-oil rival (Bamboo Works)

Flour (China)

Wudeli Flour Group

Private

—

Flour (China)

Yihai Kerry Arawana flour; COFCO flour

Listed / state-owned

Scale players in general-purpose flour

Flour (premium / Japanese-style)

Japanese millers operating in China, such as Nisshin Seifun

Listed (Japan)

—

Specialty fats

Wilmar / Yihai Kerry; Fuji Oil; Bunge Loders Croklaan

Listed multinationals

Larger, technically deep specialty-fat suppliers

Home care (China)

Guangzhou Liby (立白); Nice Group (纳爱斯/雕牌); Blue Moon (藍月亮, HKEX 6993)

Private / listed

Dominant domestic detergent and dishwashing brands

Home care (multinationals)

Procter & Gamble (Joy, Tide/Ariel); Unilever (Sunlight, Omo); Kao; Lion Corporation

Listed

Global scale and marketing budgets; strong presence in Hong Kong retail

Peer Comparison FY2026

CompanyLatest FY revenueRevenue growthNet margin

Lam Soon (HK), FY Jun-2026

HK$5.06bn (about US$0.65bn)

+4.8%5.8%

Yihai Kerry Arawana, FY2024

About RMB 239bn

——

Wilmar International, FY2024

About US$67bn

——

Procter & Gamble, FY Jun-2025

About US$84bn

About flat

—

Recent Developments

There were no layoffs, litigation or regulatory actions in the period. Headcount fell slightly to about 1,480.

Company Snapshot

$649.9M

Revenue

1,480

Employees

1961

Founded

New Territories, Hong Kong

Headquarters

SWOT Analysis

Strengths

  • Net cash balance sheet: HK$2,059 million in cash, no bank borrowings and an equity-to-debt ratio of 100:0 at 30 Jun 2026 (FY2026 results). Net cash is about 77% of the HK$2.68 billion market capitalization.
  • High return on operating capital: about 18% post-tax ROIC excluding cash in FY2026 and about 21% in FY2025 (derived from the FY2026 results).
  • Brand leadership in Hong Kong: AXE leads dishwashing (FY2026 results) and Knife leads retail peanut oil (FY2022 results). Both brands date back decades (Knife 1948, AXE 1969).
  • Tax-advantaged flour profits: flour milling profits are exempt from PRC corporate income tax (FY2026 note 6). The group's effective tax rate is 15.8% versus a 25% PRC standard rate.
  • Improving working capital: inventory days fell from 81 to 70 and receivable days from 24 to 23 in FY2026 (FY2026 results).
  • Consistent, rising dividends: DPS of HK$0.50 in FY2026, the highest of FY2019–FY2026, with a payout ratio of 40%. TSR is about 80% over 10 years versus a share-price gain of about 30% (Bamboo Works).
  • Premium flour capability: Japanese-style flour production in both North and East China after the Qingzhou upgrade (FY2026 results).

Weaknesses

  • Low and declining net margin: 5.8% in FY2026, down from 6.3% in FY2025; 1.7% at the FY2023 trough (results announcements).
  • Shrinking top line over five years: revenue CAGR of −4.6% from FY2022 to FY2026 (derived).
  • Over-capitalization dilutes returns: ROE is only 8.9% in FY2026, because cash makes up about 50% of total assets (derived).
  • Management turnover: three CEOs between April 2024 and May 2025 (HKEX announcements).
  • Rising selling costs: S&D expenses rose 7% to HK$644 million, outpacing 5% revenue growth (FY2026 results).
  • Thin liquidity and investor neglect: average daily volume of about 2,769 shares (TipRanks), no analyst coverage (Simply Wall St) and institutional ownership of about 0.14%.

Opportunities

  • Conghua plant (RMB337 million): capacity, automation and integrated R&D from FY2026/27 could restore Home Care margins at scale (TipRanks; FY2026 results).
  • Customer-specific flour and fats solutions: strong sales and gross-profit growth in FY2026 (FY2026 results). This is a higher-margin B2B growth vector.
  • Health-oriented edible oil: the zero-trans-fat and non-GMO Knife range and the GASC Training Bureau collaboration (FY2026 results).
  • Home Care beyond dishwashing: the Shanghai R&D hub, opened Q2 2026, supports adjacent categories (FY2026 results).
  • Capital return or privatization: HK$2.06 billion of cash and a P/B of about 0.8x create scope for special dividends, buybacks, or a take-private offer at a premium (Bamboo Works speculation; unconfirmed).
  • Commodity normalization: if petroleum-linked inputs ease, Home Care margins could recover toward the roughly 10% of FY2025 from 6.3% in FY2026 (FY2026 results, note 3).

Threats

  • Commodity shocks: wheat costs from the Ukraine war drove a 67% profit fall in FY2023 (profit warning, 31 Jul 2023). The Middle East conflict drove a 30% Home Care profit fall in FY2026.
  • Weak Mainland consumption and channel disruption: cautious consumption and channel shifts were cited in both FY2025 and FY2026; Mainland China is 86% of revenue.
  • Intensifying Hong Kong price competition: Hong Kong and Macau revenue fell 0.4% in FY2026 amid retailer discounting and cross-border price comparison.
  • RMB currency exposure: most revenue is earned in RMB and 36% of cash is held in RMB. FY2023 revenue was hurt by RMB depreciation, while FY2026 benefited from a HK$97.5 million translation gain (results announcements).
  • Policy risk on the CIT exemption: any change to the PRC agricultural primary-processing tax exemption would raise the group's tax rate (FY2026 note 6).
  • Scale competitors: COFCO, Yihai Kerry, Liby, P&G and Unilever have far larger marketing and procurement budgets.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
15 Apr 2025Announcement: CEO James Chiu resigns; Lim Shueh Hann named CEO and ED effective 1 May 2025Third CEO in about 13 months; internal Home Care leader promoted
1 May 2025Lim Shueh Hann takes office as CEOContinuity under an insider with e-commerce and corporate development experience
Aug 2025Company secretary changed to Stella Lo Sze Man by written resolutionMinor CG Code deviation (C.6.2) disclosed
16 Sep 2025FY2025 results: revenue HK$4,829 million (flat), gross profit +10%, profit +51% to HK$303 million, EPS HK$1.29; final DPS HK$0.33Margin-led recovery, helped by cheaper wheat and oil
Sep 2025 (week after results)Shares rise about 4.7% week-on-weekMarket response to the profit recovery (Simply Wall St)
12 Nov 2025AGM approves all resolutions; Whang Sun Tze retires; Lester Huang steps down; Whang Yixiang Remus (NED) and INEDs Cheung Man Ying and Chau Siu Lun appointedBoard refresh; Whang family generational change
4 Dec 2025FY2025 final dividend of HK$0.33 paid—
Feb 2026Board meeting notice for interim results on 25 Feb 2026Routine
25 Feb 2026H1 FY2026 interim results: revenue HK$2.67 billion (−0.4%), profit HK$176 million (−6.5%), EPS HK$0.75; Food revenue −1.7% and operating profit −5.5%; Home Care revenue +5.7% and operating profit −27%; interim DPS HK$0.15Input cost pressure starts in Home Care
10–12 Mar 2026Interim dividend ex-date 10 Mar; record date 12 Mar—
25 Mar 2026Interim dividend of HK$0.15 paid—
H2 FY2026 (Jan–Jun 2026)Escalating Middle East conflict sharply raises petroleum-linked inputs (surfactants, plastic packaging)Main driver of the 30% fall in Home Care profit for FY2026
Q2 2026Shanghai Home Care R&D hub launchedInnovation capacity beyond dishwashing
FY2026Qingzhou flour line upgrade starts productionPremium Japanese-style flour supplied locally in North China
FY2026Knife zero-trans-fat health range launched in Hong Kong with Carlos Chan campaignBrand rejuvenation against price competition
FY2026Inaugural HK and Macau regional selection of the Golden Statue CupBakery ecosystem positioning
FY2026Share-scheme trustee buys 229,000 shares for about HK$2.56 millionEmployee incentive funding
30 Jun 2026Share price HK$11.30; 52-week range HK$9.90–13.00 (Google Finance snapshot)—
7 Sep 2026FY2026 results: revenue +5% to HK$5,063 million; gross profit +4%; operating profit −3%; profit −3% to HK$293 million; EPS HK$1.25; final DPS raised to HK$0.35 (total HK$0.50); cash HK$2,059 million; no borrowings; capex HK$129 millionFirst revenue growth since FY2022; record dividend per share
Sep 2026Shares rise about 4% to around HK$11 after the dividend increaseMarket rewards payout growth (Bamboo Works)
15 Sep 2026Bamboo Works article raises privatization speculationUnconfirmed; highlights the valuation gap
FY2026 (ongoing)Conghua plant construction on trackCapacity and automation from FY2026/27
11 Nov 2026 (scheduled)AGM; register closed 6–11 Nov 2026Vote on final dividend and directors
18 Nov 2026 (scheduled)Record date for final dividend—
3 Dec 2026 (scheduled)Final dividend of HK$0.35 payable—

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

8 charts
Income Statement: Revenue & Gross Profit: Revenue rose from HKD 4,829.2 Mn in FY2025 to HKD 5,063.1 Mn in FY2026.
Lam Soon (Hong Kong) Limited — Income Statement: Revenue & Gross Profit
Series (HKD Mn)FY2025FY2026
Revenue4,829.25,063.1
Cost of sales3,710.73,903.3
Gross profit1,118.51,159.8

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.